Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_assertion type Assertion NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_head.
- NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_assertion wasGeneratedBy ECO_0000203 NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_provenance.
- NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_assertion wasDerivedFrom befree-20140225 NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_provenance.
- NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_assertion SIO_000772 16030188 NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_provenance.
- NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_assertion evidence source_evidence_literature NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_provenance.
- NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_assertion description "[We tested its effectiveness against fusion tyrosine kinases TEL-platelet-derived growth factor receptorbeta (TEL-PDGFRbeta) and FIP1-like-1 (FIP1L1)-PDGFRalpha, which cause chronic myelomonocytic leukemia and hypereosinophilic syndrome, respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP810212.RAJ76R0l-WidxUCrZ0prIpZad0t3xNjItltXTUrp3fqMY130_provenance.